BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7502694)

  • 1. Vasoactive peptides and uterine vessels.
    Stjernquist M; Bodelsson G; Poulsen H
    Gynecol Endocrinol; 1995 Jun; 9(2):165-76. PubMed ID: 7502694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma endothelin, atrial natriuretic peptide (ANP) and uterine and umbilical artery flow velocity waveforms in hypertensive pregnancies.
    Lumme R; Laatikainen T; Vuolteenaho O; Leppäluoto J
    Br J Obstet Gynaecol; 1992 Sep; 99(9):761-4. PubMed ID: 1420017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelin in mechanisms of local blood pressure control.
    Masaki T; Yanagisawa M; Goto K; Kimura S
    J Hypertens Suppl; 1990 Dec; 8(7):S107-12. PubMed ID: 2151332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin and endothelin antagonists: pharmacology and clinical implications.
    Lüscher TF; Wenzel RR
    Agents Actions Suppl; 1995; 45():237-53. PubMed ID: 7717186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1: immunocytochemistry, localization of binding sites, and contractile effects in human uteroplacental smooth muscle.
    Svane D; Larsson B; Alm P; Andersson KE; Forman A
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):233-41. PubMed ID: 8420333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-renin-angiotensin-atrial natriuretic peptide system in ovaries: an intraovarian ERAANP system.
    Usuki S; Saitoh T; Saitoh M; Tanaka J; Kawakura Y; Usuki Y; Shinjo M; Kim SJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S207-10. PubMed ID: 7509946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism between the vascular renin-angiotensin and natriuretic peptide systems in vascular remodelling.
    Itoh H; Nakao K
    Blood Press Suppl; 1994; 5():49-53. PubMed ID: 7534179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide counteracts the vasoconstrictor effects of 5-hydroxytryptamine, U46619 and endothelin-1 in the human umbilical artery.
    Templeton AG; Kingdom JC; Macmillan JB; McGrath JC; Whittle MJ
    Placenta; 1994 Oct; 15(7):715-20. PubMed ID: 7838827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide antagonizes the contractile effect of angiotensin II in the human uterine artery.
    Poulsen H; Sjöberg NO; Stjernquist M; Zia E
    Hum Reprod; 1994 Oct; 9(10):1939-43. PubMed ID: 7844230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue.
    Howard PG; Plumpton C; Davenport AP
    J Hypertens; 1992 Nov; 10(11):1379-86. PubMed ID: 1336523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smooth muscle dilatation in the human uterine artery induced by substance P, vasoactive intestinal polypeptide, calcitonin gene-related peptide and atrial natriuretic peptide: relation to endothelium-derived relaxing substances.
    Bodelsson G; Stjernquist M
    Hum Reprod; 1992 Oct; 7(9):1185-8. PubMed ID: 1282518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.
    Yamamoto K; Masuyama T; Sakata Y; Doi R; Ono K; Mano T; Kondo H; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Jun; 46(3):421-32. PubMed ID: 10912453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin peptides: biological activities, cellular signalling and clinical significance.
    Leppäluoto J; Ruskoaho H
    Ann Med; 1992 Jun; 24(3):153-61. PubMed ID: 1385714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium as an endocrine organ.
    Inagami T; Naruse M; Hoover R
    Annu Rev Physiol; 1995; 57():171-89. PubMed ID: 7778863
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelin-1: a potent vasoactive peptide.
    Schini VB; Vanhoutte PM
    Pharmacol Toxicol; 1991 Nov; 69(5):303-9. PubMed ID: 1803342
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelin, vascular hypertrophy, and hypertension.
    Rosendorff C
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):795-802. PubMed ID: 9110124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function.
    Masaki T; Kimura S; Yanagisawa M; Goto K
    Circulation; 1991 Oct; 84(4):1457-68. PubMed ID: 1655302
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasticity of contractile endothelin-B receptors in human arteries after organ culture.
    Adner M; Cantera L; Ehlert F; Nilsson L; Edvinsson L
    Br J Pharmacol; 1996 Nov; 119(6):1159-66. PubMed ID: 8937719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.